Resistant and uncontrolled hypertension is a challenge for specialists caring for these often complex co-morbid patients. Excess aldosterone resulting from over-activation of the Renin-Angiotensin-Adosterone system is a common but under-recognised driver of this condition.

In the third of this 3-part series, Dr Om Narayan and the panel discuss a case highlighting the management challenges of resistant hypertension in multi-morbid patients.

Prof Markus Schlaich
Dobney Chair in Clinical Research, The University of Western Australia; Nephrologist and Hypertension Specialist, Royal Perth Hospital; President, Hypertension Australia; Co-Lead, National Hypertension Taskforce, ACvA.

Prof Jun Yang
Consultant Endocrinologist, Monash Health; Head, Endocrine Hypertension Research Group, Hudson Institute of Medical Research; Senior Research Fellow, Monash University.

Dr Om Narayan
Interventional Cardiologist, Northern Hospital and Bendigo Hospital; Clinical Lead of the Hypertension Service, Northern Heart.

This video was created independently by the limbic. All content was developed by the presenters and views are those of the presenters alone.

Thank you to AstraZeneca for providing the unrestricted educational grant that made this project possible.